BioCardia, Inc.(BCDA)
Biotechnology
Cell Therapy (CAR-T, etc.)
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-09 | Altman Peter President and CEO | Purchase | +5,000 | +1.70%298,266 | $0.85 | $4,250 | View SEC filing | |
| 2026-05-21 | Altman Peter President and CEO | Purchase | +1,700 | +0.58%293,266 | $0.92 | $1,570 | View SEC filing | |
| 2026-05-18 | Altman Peter President and CEO | Purchase | +5,700 | +1.99%291,566 | $0.92 | $5,244 | View SEC filing | |
| 2026-04-29 | Altman Peter President and CEO | Purchase | +5,000 | +1.81%280,766 | $1.11 | $5,550 | View SEC filing | |
| 2026-04-22 | Altman Peter President and CEO | Purchase | +1,000 | +0.36%275,766 | $1.23 | $1,230 | View SEC filing | |
| 2026-03-26 | Altman Peter President and CEO | Purchase | +900 | +0.33%274,766 | $1.23 | $1,110 | View SEC filing | |
| 2026-02-04 | Altman Peter President and CEO | Purchase | +5,000 | +1.86%273,866 | $1.13 | $5,650 | View SEC filing | |
| 2026-01-21 | Altman Peter President and CEO | Purchase | +900 | +0.34%268,866 | $1.33 | $1,194 | View SEC filing | |
| 2025-12-17 | Altman Peter President and CEO | Purchase | +1,100 | +0.41%267,966 | $1.31 | $1,444 | View SEC filing | |
| 2025-09-23 | STERTZER SIMON H Director | Purchase | +796,800 | +215.39%1,166,729 | $0.63 | $498,000 | View SEC filing | |
| 2025-09-23 | Blank Andrew Scott Director | Purchase | +576,000 | +87.20%1,236,545 | $0.63 | $360,000 | View SEC filing | |
| 2025-09-23 | Altman Peter President and CEO | Purchase | +96,000 | +36.31%360,374 | $0.63 | $60,000 | View SEC filing | |
| 2025-08-25 | Altman Peter President and CEO | Purchase | +700 | +0.42%168,762 | $1.83 | $1,281 | View SEC filing | |
| 2025-08-13 | Altman Peter President and CEO | Purchase | +100 | +0.06%168,062 | $1.83 | $183 | View SEC filing | |
| 2025-08-12 | Altman Peter President and CEO | Purchase | +400 | +0.24%167,962 | $1.75 | $700 | View SEC filing | |
| 2025-08-11 | Altman Peter President and CEO | Purchase | +1,700 | +1.02%167,562 | $1.76 | $2,989 | View SEC filing | |
| 2025-07-02 | McClung David Chief Financial Officer | Purchase | +9,638 | +14.92%74,225 | $1.04 | $9,999 | View SEC filing | |
| 2025-07-02 | Altman Peter President and CEO | Purchase | +48,192 | +22.60%261,474 | $1.04 | $49,999 | View SEC filing | |
| 2025-07-02 | STERTZER SIMON H Director | Purchase | +144,578 | +64.16%369,929 | $1.04 | $150,000 | View SEC filing | |
| 2025-07-02 | Blank Andrew Scott Director | Purchase | +144,578 | +28.02%660,545 | $1.04 | $150,000 | View SEC filing | |
| 2025-05-30 | Altman Peter President and CEO | Purchase | +100 | +0.07%141,766 | $2.21 | $221 | View SEC filing | |
| 2025-05-22 | Altman Peter President and CEO | Purchase | +2,300 | +1.65%141,666 | $2.02 | $4,651 | View SEC filing | |
| 2025-05-16 | Altman Peter President and CEO | Purchase | +400 | +0.29%139,366 | $2.57 | $1,028 | View SEC filing | |
| 2025-04-28 | KRASNO RICHARD M Director | Purchase | +26,246 | +834.53%29,391 | $0.95 | $24,999 | View SEC filing | |
| 2025-04-25 | McClung David Chief Financial Officer | Purchase | +26,246 | +68.45%64,587 | $0.95 | $24,999 | View SEC filing |
1-25 of 181